Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteotomy for Hallux Valgus: a Prospective Study Using Surface 3D Scanning

ConditionHallux Valgus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGroupe Hospitalier Diaconesses Croix Saint-Simon

About this trial

Background and Rationale:

Surgical correction of Hallux Valgus via Scarf and P1 osteotomy aims to realign the first ray, modifying overall forefoot morphology. While radiological correction is well established, a discrepancy often exists between objective foot measurements and patient-perceived postoperative shoe fitting. Weight-bearing 3D surface scanning provides a non-irradiating, precise method to evaluate volumetric and dimensional changes without the biases of traditional foot-measuring gauges.

Objective and Hypothesis:

The primary objective is to measure changes in shoe size (in French/Paris points) using weight-bearing 3D surface scanning between baseline and 6 months postoperatively. The study hypothesis is that Scarf + P1 osteotomy induces a shoe size reduction of at least 0.5 Paris points at 6 months, correlated with forefoot width reduction, M1 shortening, and angular correction (HVA and M1-M2 angles).

Study Design:

Prospective, single-center, non-comparative interventional study with minimal risks and constraints (RIPH 2) involving 100 participants.

Eligibility criteria

Qualifiers

Patient informed about the study and signed written consent obtained in duplicate

Male or female participant aged 18 years or older

Symptomatic hallux valgus without lateral ray involvement, requiring surgical correction by Scarf + P1 osteotomy

Primary surgery planned for the affected foot

Disqualifiers

Previous bony surgery of the first ray or forefoot on the affected side (osteotomy, arthrodesis)

Surgical indication on lateral rays (claw toes, Weil osteotomy)

Severe lower-limb neurological or vascular disease altering gait or foot morphology (Charcot foot, critical limb ischemia, severe neuropathy)

Active inflammatory rheumatic disease (e.g., rheumatoid arthritis) with polyarticular foot involvement

Trial design

Treatments tested in this trial

  • Surgical correction of hallux valgus via osteotomy

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations